ondansetron has been researched along with Vestibular Diseases in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome." | 9.51 | Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022) |
| "The results provide preliminary evidence of the potential benefit of ondansetron in the treatment of nausea, which was present in all examined dogs." | 8.02 | The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome. ( Elliott, J; Foth, S; Kenward, H; Meller, S; Pelligand, L; Volk, HA, 2021) |
| "To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome." | 5.51 | Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022) |
| "The results provide preliminary evidence of the potential benefit of ondansetron in the treatment of nausea, which was present in all examined dogs." | 4.02 | The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome. ( Elliott, J; Foth, S; Kenward, H; Meller, S; Pelligand, L; Volk, HA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henze, L | 1 |
| Foth, S | 2 |
| Meller, S | 2 |
| Twele, F | 1 |
| Charalambous, M | 1 |
| Kenward, H | 2 |
| Elliott, J | 2 |
| Pelligand, L | 2 |
| Volk, HA | 2 |
1 trial available for ondansetron and Vestibular Diseases
| Article | Year |
|---|---|
Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
Topics: Animals; Antiemetics; Arginine Vasopressin; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Met | 2022 |
1 other study available for ondansetron and Vestibular Diseases
| Article | Year |
|---|---|
The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.
Topics: Administration, Intravenous; Animals; Antiemetics; Dogs; Nausea; Ondansetron; Vestibular Diseases; V | 2021 |